← ANALYST RATINGS · TIPRANKS

OptimizeRx (OPRX): analyst forecast and price target

$8.50 −3.95% close 16.10.26 · market cap $161M · Healthcare · Medical - Healthcare Information Services
Price targets and ratings of

Analyst consensus

Strong Buy

5 Buy0 Hold0 Sell

Ratings of 5 analysts in the last 3 months

12-month forecast

$13.00+52.9% upside

Based on 5 price targets given in the last 3 months, the average target is $13.00, the highest $18.00, the lowest $11.00. The average is +52.9% from the last price of $8.50.

$5.00$10.00$15.00$20.00Jan 26AprJulOctJan 27AprJulOctHigh$18.00Average$13.00Low$11.00
Highest target $18.00 Average target $13.00 Lowest target $11.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Ryan Daniels★★★★★★★★★★#2878 · hits 48% · avg +5.8% William Blair — Buy — Reiterated 02.10.26on TipRanks 16:45 +1.1%next day +0.5% · 5 days −6.2%
Josh Nichols★★★★★★★★★★#907 · hits 48% · avg +13.7% B. Riley Securities $10.00 → $11.00+10.0% Buy +29.4% Reiterated 29.09.26on TipRanks 08:40 +7.2%next day +0.1% · 5 days +3.4%
Richard Baldry★★★★★★★★★★#615 · hits 56% · avg +13.5% Roth MKM $18.00 Buy +111.8% Reiterated 13.08.26on TipRanks 11:25 +24.0%next day −0.5% · 5 days −7.4%
Eric Martinuzzi★★★★★★★★★★#797 · hits 51% · avg +11.7% Lake Street $11.00 Buy +29.4% Reiterated 13.08.26on TipRanks 09:30 +24.0%next day −0.5% · 5 days −7.4%
David Grossman★★★★★★★★★★#4304 · hits 49% · avg +2.3% Stifel Nicolaus $14.00 → $12.00−14.3% Buy +41.2% Reiterated 13.08.26on TipRanks 07:35 +24.0%next day −0.5% · 5 days −7.4%
Jeffrey Garro★★★★★★★★★★#12266 · hits 30% · avg −24.4% Stephens $7.00 Hold −17.6% Assigned 13.05.26on TipRanks 07:40 −23.0%next day +4.6% · 5 days +1.3%
Constantine Davides★★★★★★★★★★#12158 · hits 36% · avg −12.7% Citizens JMP $23.00 → $24.00+4.3% Buy +182.4% Reiterated 07.11.25on TipRanks 17:05 +3.9%next day −4.0% · 5 days −8.1%

The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included

Best analysts covering OptimizeRx

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Richard Baldry★★★★★★★★★★Roth MKM · #615
Hits 56%250 of 445 Average return +13.5%
1 year Constantine Davides★★★★★★★★★★Citizens JMP · #12158
Hits 36%51 of 140 Average return −12.7%
2 years Eric Martinuzzi★★★★★★★★★★Lake Street · #797
Hits 51%249 of 488 Average return +11.7%

Most profitable

3 months Richard Baldry★★★★★★★★★★Roth MKM · #615
Hits 56%250 of 445 Average return +13.5%
1 year Constantine Davides★★★★★★★★★★Citizens JMP · #12158
Hits 36%51 of 140 Average return −12.7%
2 years Eric Martinuzzi★★★★★★★★★★Lake Street · #797
Hits 51%249 of 488 Average return +11.7%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 02.10.26: target $13.00 at a price of $8.39 (+54.9%); now: $13.00 at $8.50 (+52.9%).

$8.00$10.00$12.00Sep 15Oct 1Oct 15Top analysts$13.00Average target$13.00Price$8.50

PriceAverage targetTop analysts’ target

Recommendation trend

05101517Oct 25541Nov741Dec831Jan 263Feb711Mar721Apr1132May521Jun411Jul13Aug14Sep15Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy1154111
Buy321345
Hold211000
Sell000000

Earnings and sales forecast

Next report: 10.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $0.17 (from $0.10 to $0.22). Last quarter: $0.16.

Sales

Next quarter’s sales estimate — $21M (from $20M to $22M). Last quarter: $21M.

Best top-analyst consensus in the sector · Healthcare

OVIDOvid Therapeutics
AXGNAxoGen
PTGXProtagonist TherapeuticsStrong Buy
ESTAEstablishment Labs HoldingsStrong Buy
REPLReplimune GroupStrong Buy
About OptimizeRx
  • CEO: Stephen L. Silvestro
  • Employees: 133
  • 260 Charles Street, Waltham, MA, 02453, US
  • www.optimizerx.com

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.

Data from the stock’s TipRanks forecast page, read 154 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗